Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma

Keiji Yoshikawa,1 Shiro Mizoue,2,3 Koji Nitta,4 Hiroshi Onishi,5 Masaharu Ikeda,5 Akemi Mizuno,5 Kaori Kawazoe,5 Yoshiyuki Tamada,5 Ryuji Takeda,6 Shun Matsumoto7 1Yoshikawa Eye Clinic, Tokyo, Japan; 2Ehime University Hospital, Toon, Ehime, Japan; 3Minami-Matsuyama Hospital, Matsuyama, Ehime, Japan;...

Full description

Bibliographic Details
Main Authors: Yoshikawa K, Mizoue S, Nitta K, Onishi H, Ikeda M, Mizuno A, Kawazoe K, Tamada Y, Takeda R, Matsumoto S
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/stratification-based-investigation-of-adjunctive-brimonidine-or-timolo-peer-reviewed-fulltext-article-OPTH
id doaj-d2d562e7ae1542c1a7e3736a11a939dd
record_format Article
spelling doaj-d2d562e7ae1542c1a7e3736a11a939dd2021-07-06T19:59:22ZengDove Medical PressClinical Ophthalmology1177-54832021-07-01Volume 152875288366664Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension GlaucomaYoshikawa KMizoue SNitta KOnishi HIkeda MMizuno AKawazoe KTamada YTakeda RMatsumoto SKeiji Yoshikawa,1 Shiro Mizoue,2,3 Koji Nitta,4 Hiroshi Onishi,5 Masaharu Ikeda,5 Akemi Mizuno,5 Kaori Kawazoe,5 Yoshiyuki Tamada,5 Ryuji Takeda,6 Shun Matsumoto7 1Yoshikawa Eye Clinic, Tokyo, Japan; 2Ehime University Hospital, Toon, Ehime, Japan; 3Minami-Matsuyama Hospital, Matsuyama, Ehime, Japan; 4Fukui-ken Saiseikai Hospital, Fukui, Japan; 5Senju Pharmaceutical Co. Ltd., Hyogo, Japan; 6Kansai University of Welfare Sciences, Osaka, Japan; 7Ideta Eye Hospital, Kumamoto, JapanCorrespondence: Keiji YoshikawaYoshikawa Eye Clinic, 1-3-1 Nakamachi, Machida, Tokyo, 194-0021, JapanTel +81-42-739-0781Fax +81-42-739-0782Email mayokasyg51@galaxy.ocn.ne.jpPurpose: We previously investigated the efficacy and safety of adding 0.1% brimonidine (Brim) or 0.5% timolol (Tim) to prostaglandin analogue (PGA) monotherapy to treat patients with normal-tension glaucoma (NTG) with intraocular pressure (IOP) of ≤ 16 mmHg. Herein, we describe an additional post-hoc stratifying analysis of the possible differences in the effect of IOP-lowering and pulse rate (PR) after adjunctive Brim or Tim to PGA.Patients and Methods: This study included 128 subjects. Patients with NTG treated with PGA were stratified based on their baseline IOP. The changes in IOP from baseline and the effect of patient factors on IOP changes were investigated. Patients were stratified by age for investigation of their PR and blood pressure (BP). The change and the effect of patient factors on PR and BP were investigated.Results: After stratification analysis, in 52 eyes treated with Brim and 61 eyes with Tim with baseline IOP 12 ≤ IOP ≤ 16 mmHg, both eye drops lowered IOP significantly (P < 0.0001), and the IOP-lowering efficacy of Brim was non-inferior to that of Tim. However, in 9 Brim- and 6 Tim-treated eyes with baseline IOP of < 12 mmHg, no statistically significant decrease in IOP was evident with either eye drop. In the Tim group, PR decreased significantly (P < 0.05) after stratification by age.Conclusion: The IOP-lowering efficacy of Brim was non-inferior to that of Tim after stratification by baseline IOP (12 ≤ IOP ≤ 16 mmHg). The discrepancy in the IOP-lowering effects of Brim and Tim observed in the previous study was thought to be related to enrolled subjects with low baseline IOP. PR decreased significantly in the Tim group even after age stratification. PR should be considered when selecting β-blockers for glaucoma treatment.Keywords: adjunctive therapy, brimonidine, intraocular pressure reduction, post-hoc analysis, pulse rate, timololhttps://www.dovepress.com/stratification-based-investigation-of-adjunctive-brimonidine-or-timolo-peer-reviewed-fulltext-article-OPTHadjunctive therapybrimonidineintraocular pressure reductionpost-hoc analysispulse ratetimolol
collection DOAJ
language English
format Article
sources DOAJ
author Yoshikawa K
Mizoue S
Nitta K
Onishi H
Ikeda M
Mizuno A
Kawazoe K
Tamada Y
Takeda R
Matsumoto S
spellingShingle Yoshikawa K
Mizoue S
Nitta K
Onishi H
Ikeda M
Mizuno A
Kawazoe K
Tamada Y
Takeda R
Matsumoto S
Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
Clinical Ophthalmology
adjunctive therapy
brimonidine
intraocular pressure reduction
post-hoc analysis
pulse rate
timolol
author_facet Yoshikawa K
Mizoue S
Nitta K
Onishi H
Ikeda M
Mizuno A
Kawazoe K
Tamada Y
Takeda R
Matsumoto S
author_sort Yoshikawa K
title Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
title_short Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
title_full Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
title_fullStr Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
title_full_unstemmed Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
title_sort stratification-based investigation of adjunctive brimonidine or timolol to a prostaglandin analogue in japanese patients with normal-tension glaucoma
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2021-07-01
description Keiji Yoshikawa,1 Shiro Mizoue,2,3 Koji Nitta,4 Hiroshi Onishi,5 Masaharu Ikeda,5 Akemi Mizuno,5 Kaori Kawazoe,5 Yoshiyuki Tamada,5 Ryuji Takeda,6 Shun Matsumoto7 1Yoshikawa Eye Clinic, Tokyo, Japan; 2Ehime University Hospital, Toon, Ehime, Japan; 3Minami-Matsuyama Hospital, Matsuyama, Ehime, Japan; 4Fukui-ken Saiseikai Hospital, Fukui, Japan; 5Senju Pharmaceutical Co. Ltd., Hyogo, Japan; 6Kansai University of Welfare Sciences, Osaka, Japan; 7Ideta Eye Hospital, Kumamoto, JapanCorrespondence: Keiji YoshikawaYoshikawa Eye Clinic, 1-3-1 Nakamachi, Machida, Tokyo, 194-0021, JapanTel +81-42-739-0781Fax +81-42-739-0782Email mayokasyg51@galaxy.ocn.ne.jpPurpose: We previously investigated the efficacy and safety of adding 0.1% brimonidine (Brim) or 0.5% timolol (Tim) to prostaglandin analogue (PGA) monotherapy to treat patients with normal-tension glaucoma (NTG) with intraocular pressure (IOP) of ≤ 16 mmHg. Herein, we describe an additional post-hoc stratifying analysis of the possible differences in the effect of IOP-lowering and pulse rate (PR) after adjunctive Brim or Tim to PGA.Patients and Methods: This study included 128 subjects. Patients with NTG treated with PGA were stratified based on their baseline IOP. The changes in IOP from baseline and the effect of patient factors on IOP changes were investigated. Patients were stratified by age for investigation of their PR and blood pressure (BP). The change and the effect of patient factors on PR and BP were investigated.Results: After stratification analysis, in 52 eyes treated with Brim and 61 eyes with Tim with baseline IOP 12 ≤ IOP ≤ 16 mmHg, both eye drops lowered IOP significantly (P < 0.0001), and the IOP-lowering efficacy of Brim was non-inferior to that of Tim. However, in 9 Brim- and 6 Tim-treated eyes with baseline IOP of < 12 mmHg, no statistically significant decrease in IOP was evident with either eye drop. In the Tim group, PR decreased significantly (P < 0.05) after stratification by age.Conclusion: The IOP-lowering efficacy of Brim was non-inferior to that of Tim after stratification by baseline IOP (12 ≤ IOP ≤ 16 mmHg). The discrepancy in the IOP-lowering effects of Brim and Tim observed in the previous study was thought to be related to enrolled subjects with low baseline IOP. PR decreased significantly in the Tim group even after age stratification. PR should be considered when selecting β-blockers for glaucoma treatment.Keywords: adjunctive therapy, brimonidine, intraocular pressure reduction, post-hoc analysis, pulse rate, timolol
topic adjunctive therapy
brimonidine
intraocular pressure reduction
post-hoc analysis
pulse rate
timolol
url https://www.dovepress.com/stratification-based-investigation-of-adjunctive-brimonidine-or-timolo-peer-reviewed-fulltext-article-OPTH
work_keys_str_mv AT yoshikawak stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT mizoues stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT nittak stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT onishih stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT ikedam stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT mizunoa stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT kawazoek stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT tamaday stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT takedar stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
AT matsumotos stratificationbasedinvestigationofadjunctivebrimonidineortimololtoaprostaglandinanalogueinjapanesepatientswithnormaltensionglaucoma
_version_ 1721317132735610880